Cystinosis

"Cystinosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME.


expand / collapse Publications
This graph shows the total number of publications written about "Cystinosis" by people in this website by year, and whether "Cystinosis" was a major or minor topic of these publications.
Below are the most recent publications written about "Cystinosis" by people in Profiles.
  1. Cystinosin regulates Na+/H+ exchanger 3 trafficking and function in kidney proximal tubular cells. EMBO Rep. 2026 Apr; 27(8):2088-2117.
    View in: PubMed
  2. Hematopoietic Stem-Cell Gene Therapy for Cystinosis. N Engl J Med. 2026 Feb 19; 394(8):753-762.
    View in: PubMed
  3. Comprehensive Ocular Characteristics in Cystinosis after Hematopoietic Stem-Cell Gene Therapy Over 24 Months. Am J Ophthalmol. 2026 May; 285:288-299.
    View in: PubMed
  4. Introducing the University of California, Irvine Corneal Cystine Crystal Score: A Novel Tool for Assessing Corneal Crystal Deposition in Cystinosis Patients. Sci Rep. 2025 Oct 16; 15(1):36262.
    View in: PubMed
  5. Novel mechanism for tubular injury in nephropathic cystinosis. Elife. 2025 Mar 20; 13.
    View in: PubMed
  6. Reconstitution of Rab11-FIP4 Expression Rescues Cellular Homeostasis in Cystinosis. Mol Cell Biol. 2024; 44(12):577-589.
    View in: PubMed
  7. Leptin signalling altered in infantile nephropathic cystinosis-related bone disorder. J Cachexia Sarcopenia Muscle. 2024 Dec; 15(6):2447-2459.
    View in: PubMed
  8. The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo. Exp Eye Res. 2023 01; 226:109338.
    View in: PubMed
  9. Metabolic Advantage of 25(OH)D3 versus 1,25(OH)2D3 Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting. Cells. 2022 10 17; 11(20).
    View in: PubMed
  10. A Personal History of Cystinosis by Dr. Jerry Schneider. Cells. 2022 03 10; 11(6).
    View in: PubMed